instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Tachycardia'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Tachypnoea'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Toxicity to various agents'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 19,929,210 | 2021 |
What was the outcome of reaction 'Troponin increased'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Vomiting'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What is the weight of the patient? | COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation.
We report the case of a 65-year-old man with COVID-19 (coronavirus disease-2019) post-infectious encephalitis who presented with delirium as an initial manifestation. He had severe COVID-19 pneumonia and recovered with dexametha... | 106 kg. | Weight | CC BY-NC | 34229469 | 20,733,184 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation.
We report the case of a 65-year-old man with COVID-19 (coronavirus disease-2019) post-infectious encephalitis who presented with delirium as an initial manifestation. He had severe COVID-19 pneumonia and recovered with dexametha... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34229469 | 20,733,184 | 2021 |
What was the administration route of drug 'PREDNISOLONE'? | COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation.
We report the case of a 65-year-old man with COVID-19 (coronavirus disease-2019) post-infectious encephalitis who presented with delirium as an initial manifestation. He had severe COVID-19 pneumonia and recovered with dexametha... | Oral | DrugAdministrationRoute | CC BY-NC | 34229469 | 20,733,184 | 2021 |
What was the administration route of drug 'TOCILIZUMAB'? | COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation.
We report the case of a 65-year-old man with COVID-19 (coronavirus disease-2019) post-infectious encephalitis who presented with delirium as an initial manifestation. He had severe COVID-19 pneumonia and recovered with dexametha... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34229469 | 20,728,845 | 2021 |
What was the dosage of drug 'TOCILIZUMAB'? | COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation.
We report the case of a 65-year-old man with COVID-19 (coronavirus disease-2019) post-infectious encephalitis who presented with delirium as an initial manifestation. He had severe COVID-19 pneumonia and recovered with dexametha... | 8 MILLIGRAM/KILOGRAM, SINGLE INFUSION | DrugDosageText | CC BY-NC | 34229469 | 20,728,845 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Back pain'. | Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
Clozapine has a unique efficacy profile among individuals suffering from treatment-resistant schizophrenia, but is associated with hematological side effects. The use of granulocyte colony-stimulating factors ... | CLOZAPINE, FILGRASTIM | DrugsGivenReaction | CC BY | 34229529 | 17,678,616 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Choking'. | Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
Clozapine has a unique efficacy profile among individuals suffering from treatment-resistant schizophrenia, but is associated with hematological side effects. The use of granulocyte colony-stimulating factors ... | CLOZAPINE, FILGRASTIM | DrugsGivenReaction | CC BY | 34229529 | 19,579,266 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug effective for unapproved indication'. | Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
Clozapine has a unique efficacy profile among individuals suffering from treatment-resistant schizophrenia, but is associated with hematological side effects. The use of granulocyte colony-stimulating factors ... | CLOZAPINE, FILGRASTIM | DrugsGivenReaction | CC BY | 34229529 | 19,579,266 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatitis'. | Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
Clozapine has a unique efficacy profile among individuals suffering from treatment-resistant schizophrenia, but is associated with hematological side effects. The use of granulocyte colony-stimulating factors ... | CLOZAPINE, FILGRASTIM | DrugsGivenReaction | CC BY | 34229529 | 19,579,757 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
Clozapine has a unique efficacy profile among individuals suffering from treatment-resistant schizophrenia, but is associated with hematological side effects. The use of granulocyte colony-stimulating factors ... | CLOZAPINE, FILGRASTIM | DrugsGivenReaction | CC BY | 34229529 | 19,579,757 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Psychotic disorder'. | Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
Clozapine has a unique efficacy profile among individuals suffering from treatment-resistant schizophrenia, but is associated with hematological side effects. The use of granulocyte colony-stimulating factors ... | CLOZAPINE, FILGRASTIM | DrugsGivenReaction | CC BY | 34229529 | 19,579,757 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
Clozapine has a unique efficacy profile among individuals suffering from treatment-resistant schizophrenia, but is associated with hematological side effects. The use of granulocyte colony-stimulating factors ... | CLOZAPINE, VALPROIC ACID | DrugsGivenReaction | CC BY | 34229529 | 19,636,372 | 2021-09 |
What was the administration route of drug 'FILGRASTIM'? | Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
Clozapine has a unique efficacy profile among individuals suffering from treatment-resistant schizophrenia, but is associated with hematological side effects. The use of granulocyte colony-stimulating factors ... | Subcutaneous | DrugAdministrationRoute | CC BY | 34229529 | 19,592,798 | 2021-09 |
What was the outcome of reaction 'Agranulocytosis'? | Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
Clozapine has a unique efficacy profile among individuals suffering from treatment-resistant schizophrenia, but is associated with hematological side effects. The use of granulocyte colony-stimulating factors ... | Recovered | ReactionOutcome | CC BY | 34229529 | 19,636,372 | 2021-09 |
What was the outcome of reaction 'Back pain'? | Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
Clozapine has a unique efficacy profile among individuals suffering from treatment-resistant schizophrenia, but is associated with hematological side effects. The use of granulocyte colony-stimulating factors ... | Recovered | ReactionOutcome | CC BY | 34229529 | 17,678,616 | 2021-09 |
What was the outcome of reaction 'Choking'? | Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
Clozapine has a unique efficacy profile among individuals suffering from treatment-resistant schizophrenia, but is associated with hematological side effects. The use of granulocyte colony-stimulating factors ... | Fatal | ReactionOutcome | CC BY | 34229529 | 19,579,266 | 2021-09 |
What was the outcome of reaction 'Neutropenia'? | Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
Clozapine has a unique efficacy profile among individuals suffering from treatment-resistant schizophrenia, but is associated with hematological side effects. The use of granulocyte colony-stimulating factors ... | Recovered | ReactionOutcome | CC BY | 34229529 | 17,678,616 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lichenoid keratosis'. | Evaluating T-cell cross-reactivity between tumors and immune-related adverse events with TCR sequencing: pitfalls in interpretations of functional relevance.
T-cell receptor sequencing (TCRseq) enables tracking of T-cell clonotypes recognizing the same antigen over time and across biological compartments. TCRseq has be... | NIVOLUMAB | DrugsGivenReaction | CC BY-NC | 34230111 | 19,602,446 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eye haemorrhage'. | Apixaban concentration variability and relation to clinical outcomes in real-life patients with atrial fibrillation.
In some clinical situations, measurements of anticoagulant effect of apixaban may be needed. We investigated the inter- and intra-individual apixaban variability in patients with atrial fibrillation and ... | APIXABAN | DrugsGivenReaction | CC BY | 34230559 | 20,643,434 | 2021-07-06 |
What was the administration route of drug 'APIXABAN'? | Apixaban concentration variability and relation to clinical outcomes in real-life patients with atrial fibrillation.
In some clinical situations, measurements of anticoagulant effect of apixaban may be needed. We investigated the inter- and intra-individual apixaban variability in patients with atrial fibrillation and ... | Oral | DrugAdministrationRoute | CC BY | 34230559 | 20,643,434 | 2021-07-06 |
What was the dosage of drug 'APIXABAN'? | Apixaban concentration variability and relation to clinical outcomes in real-life patients with atrial fibrillation.
In some clinical situations, measurements of anticoagulant effect of apixaban may be needed. We investigated the inter- and intra-individual apixaban variability in patients with atrial fibrillation and ... | UNK, BID | DrugDosageText | CC BY | 34230559 | 20,643,434 | 2021-07-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Red face may be a specific sign of SARS-CoV-2 alpha variant.
Japan is currently suffering the fourth wave of the COVID-19 pandemic, with the dominant type being SARS-CoV-2 alpha variant. Patients with COVID-19 variant types show more aggressive symptoms. In the present study, three patients developed a red face during ... | DEXAMETHASONE, FAVIPIRAVIR | DrugsGivenReaction | CC BY-NC-ND | 34230877 | 19,826,873 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Erythema'. | Red face may be a specific sign of SARS-CoV-2 alpha variant.
Japan is currently suffering the fourth wave of the COVID-19 pandemic, with the dominant type being SARS-CoV-2 alpha variant. Patients with COVID-19 variant types show more aggressive symptoms. In the present study, three patients developed a red face during ... | DEXAMETHASONE, FAVIPIRAVIR | DrugsGivenReaction | CC BY-NC-ND | 34230877 | 19,826,857 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperglycaemia'. | Red face may be a specific sign of SARS-CoV-2 alpha variant.
Japan is currently suffering the fourth wave of the COVID-19 pandemic, with the dominant type being SARS-CoV-2 alpha variant. Patients with COVID-19 variant types show more aggressive symptoms. In the present study, three patients developed a red face during ... | DEXAMETHASONE, FAVIPIRAVIR | DrugsGivenReaction | CC BY-NC-ND | 34230877 | 19,826,857 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Red face may be a specific sign of SARS-CoV-2 alpha variant.
Japan is currently suffering the fourth wave of the COVID-19 pandemic, with the dominant type being SARS-CoV-2 alpha variant. Patients with COVID-19 variant types show more aggressive symptoms. In the present study, three patients developed a red face during ... | DEXAMETHASONE, FAVIPIRAVIR | DrugsGivenReaction | CC BY-NC-ND | 34230877 | 19,667,451 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Red face may be a specific sign of SARS-CoV-2 alpha variant.
Japan is currently suffering the fourth wave of the COVID-19 pandemic, with the dominant type being SARS-CoV-2 alpha variant. Patients with COVID-19 variant types show more aggressive symptoms. In the present study, three patients developed a red face during ... | DEXAMETHASONE, FAVIPIRAVIR | DrugsGivenReaction | CC BY-NC-ND | 34230877 | 19,826,857 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Red face may be a specific sign of SARS-CoV-2 alpha variant.
Japan is currently suffering the fourth wave of the COVID-19 pandemic, with the dominant type being SARS-CoV-2 alpha variant. Patients with COVID-19 variant types show more aggressive symptoms. In the present study, three patients developed a red face during ... | DEXAMETHASONE, FAVIPIRAVIR | DrugsGivenReaction | CC BY-NC-ND | 34230877 | 19,826,857 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Unmasking of previously unidentified disease'. | Red face may be a specific sign of SARS-CoV-2 alpha variant.
Japan is currently suffering the fourth wave of the COVID-19 pandemic, with the dominant type being SARS-CoV-2 alpha variant. Patients with COVID-19 variant types show more aggressive symptoms. In the present study, three patients developed a red face during ... | DEXAMETHASONE, FAVIPIRAVIR | DrugsGivenReaction | CC BY-NC-ND | 34230877 | 19,826,873 | 2021 |
What was the outcome of reaction 'Erythema'? | Red face may be a specific sign of SARS-CoV-2 alpha variant.
Japan is currently suffering the fourth wave of the COVID-19 pandemic, with the dominant type being SARS-CoV-2 alpha variant. Patients with COVID-19 variant types show more aggressive symptoms. In the present study, three patients developed a red face during ... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34230877 | 19,826,857 | 2021 |
What was the outcome of reaction 'Hyperglycaemia'? | Red face may be a specific sign of SARS-CoV-2 alpha variant.
Japan is currently suffering the fourth wave of the COVID-19 pandemic, with the dominant type being SARS-CoV-2 alpha variant. Patients with COVID-19 variant types show more aggressive symptoms. In the present study, three patients developed a red face during ... | Recovering | ReactionOutcome | CC BY-NC-ND | 34230877 | 19,667,451 | 2021 |
What was the outcome of reaction 'Pyrexia'? | Red face may be a specific sign of SARS-CoV-2 alpha variant.
Japan is currently suffering the fourth wave of the COVID-19 pandemic, with the dominant type being SARS-CoV-2 alpha variant. Patients with COVID-19 variant types show more aggressive symptoms. In the present study, three patients developed a red face during ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34230877 | 19,826,857 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dermatitis bullous'. | Cutaneous Adverse Events to Targeted Therapies and Immuno-therapies in Children: A Retrospective Study of 103 Patients from Two Tertiary Haemato-Oncology Referral Centres.
Targeted medications and immunotherapies are being developed to specifically target the pathways involved in tumours. There is limited experience wi... | DABRAFENIB | DrugsGivenReaction | CC BY-NC | 34230982 | 20,003,432 | 2021-07-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Severe hypercalcemia associated with hypophosphatemia in very premature infants: a case report.
BACKGROUND
Severe hypercalcemia is rare in newborns; even though often asymptomatic, it may have important sequelae. Hypophosphatemia can occur in infants experiencing intrauterine malnutrition, sepsis and early high-energy ... | ALBUMIN HUMAN, FUROSEMIDE, SODIUM GLYCEROPHOSPHATE | DrugsGivenReaction | CC BY | 34233724 | 20,198,938 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Severe hypercalcemia associated with hypophosphatemia in very premature infants: a case report.
BACKGROUND
Severe hypercalcemia is rare in newborns; even though often asymptomatic, it may have important sequelae. Hypophosphatemia can occur in infants experiencing intrauterine malnutrition, sepsis and early high-energy ... | ALBUMIN HUMAN, FUROSEMIDE, SODIUM GLYCEROPHOSPHATE | DrugsGivenReaction | CC BY | 34233724 | 20,198,938 | 2021-07-07 |
What was the administration route of drug 'FUROSEMIDE'? | Severe hypercalcemia associated with hypophosphatemia in very premature infants: a case report.
BACKGROUND
Severe hypercalcemia is rare in newborns; even though often asymptomatic, it may have important sequelae. Hypophosphatemia can occur in infants experiencing intrauterine malnutrition, sepsis and early high-energy ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34233724 | 20,198,938 | 2021-07-07 |
What was the administration route of drug 'SODIUM GLYCEROPHOSPHATE'? | Severe hypercalcemia associated with hypophosphatemia in very premature infants: a case report.
BACKGROUND
Severe hypercalcemia is rare in newborns; even though often asymptomatic, it may have important sequelae. Hypophosphatemia can occur in infants experiencing intrauterine malnutrition, sepsis and early high-energy ... | Parenteral | DrugAdministrationRoute | CC BY | 34233724 | 20,198,938 | 2021-07-07 |
What was the dosage of drug 'ALBUMIN HUMAN'? | Severe hypercalcemia associated with hypophosphatemia in very premature infants: a case report.
BACKGROUND
Severe hypercalcemia is rare in newborns; even though often asymptomatic, it may have important sequelae. Hypophosphatemia can occur in infants experiencing intrauterine malnutrition, sepsis and early high-energy ... | UNK, INFUSION | DrugDosageText | CC BY | 34233724 | 20,198,938 | 2021-07-07 |
What was the dosage of drug 'FUROSEMIDE'? | Severe hypercalcemia associated with hypophosphatemia in very premature infants: a case report.
BACKGROUND
Severe hypercalcemia is rare in newborns; even though often asymptomatic, it may have important sequelae. Hypophosphatemia can occur in infants experiencing intrauterine malnutrition, sepsis and early high-energy ... | 1.5 MILLIGRAM/KILOGRAM | DrugDosageText | CC BY | 34233724 | 20,198,938 | 2021-07-07 |
What was the dosage of drug 'SODIUM GLYCEROPHOSPHATE'? | Severe hypercalcemia associated with hypophosphatemia in very premature infants: a case report.
BACKGROUND
Severe hypercalcemia is rare in newborns; even though often asymptomatic, it may have important sequelae. Hypophosphatemia can occur in infants experiencing intrauterine malnutrition, sepsis and early high-energy ... | 80 MILLIGRAM/KILOGRAM, QD, IN PARENTERAL SOLUTION | DrugDosageText | CC BY | 34233724 | 20,198,938 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | BeEAM conditioning regimen is a safe, efficacious and economical alternative to BEAM chemotherapy.
In many stem cell transplant centres, BCNU, etoposide, cytarabine and melphalan (BEAM) high-dose chemotherapy (HDCT) has been replaced by the more economic and available bendamustine, etoposide, cytarabine, melphalan (BeE... | BENDAMUSTINE HYDROCHLORIDE, CYTARABINE, ETOPOSIDE, FILGRASTIM, FLUCONAZOLE, MELPHALAN, SULFAMETHOXAZOLE\TRIMETHOPRIM, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34234243 | 19,595,674 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephropathy toxic'. | BeEAM conditioning regimen is a safe, efficacious and economical alternative to BEAM chemotherapy.
In many stem cell transplant centres, BCNU, etoposide, cytarabine and melphalan (BEAM) high-dose chemotherapy (HDCT) has been replaced by the more economic and available bendamustine, etoposide, cytarabine, melphalan (BeE... | BENDAMUSTINE HYDROCHLORIDE, CYTARABINE, ETOPOSIDE, FILGRASTIM, FLUCONAZOLE, MELPHALAN, SULFAMETHOXAZOLE\TRIMETHOPRIM, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34234243 | 19,595,674 | 2021-07-07 |
What was the administration route of drug 'FLUCONAZOLE'? | BeEAM conditioning regimen is a safe, efficacious and economical alternative to BEAM chemotherapy.
In many stem cell transplant centres, BCNU, etoposide, cytarabine and melphalan (BEAM) high-dose chemotherapy (HDCT) has been replaced by the more economic and available bendamustine, etoposide, cytarabine, melphalan (BeE... | Oral | DrugAdministrationRoute | CC BY | 34234243 | 19,595,674 | 2021-07-07 |
What was the administration route of drug 'VALACYCLOVIR HYDROCHLORIDE'? | BeEAM conditioning regimen is a safe, efficacious and economical alternative to BEAM chemotherapy.
In many stem cell transplant centres, BCNU, etoposide, cytarabine and melphalan (BEAM) high-dose chemotherapy (HDCT) has been replaced by the more economic and available bendamustine, etoposide, cytarabine, melphalan (BeE... | Oral | DrugAdministrationRoute | CC BY | 34234243 | 19,595,674 | 2021-07-07 |
What was the dosage of drug 'BENDAMUSTINE HYDROCHLORIDE'? | BeEAM conditioning regimen is a safe, efficacious and economical alternative to BEAM chemotherapy.
In many stem cell transplant centres, BCNU, etoposide, cytarabine and melphalan (BEAM) high-dose chemotherapy (HDCT) has been replaced by the more economic and available bendamustine, etoposide, cytarabine, melphalan (BeE... | A SINGLE 1?H INFUSION IN 1000 ML IN 0.9% NACL ON DAYS ? 7 AND ? 6 | DrugDosageText | CC BY | 34234243 | 19,595,674 | 2021-07-07 |
What was the dosage of drug 'CYTARABINE'? | BeEAM conditioning regimen is a safe, efficacious and economical alternative to BEAM chemotherapy.
In many stem cell transplant centres, BCNU, etoposide, cytarabine and melphalan (BEAM) high-dose chemotherapy (HDCT) has been replaced by the more economic and available bendamustine, etoposide, cytarabine, melphalan (BeE... | ON DAYS ? 5 TO ? 2, 30?MIN INFUSION IN 100 ML 0.9% NACL | DrugDosageText | CC BY | 34234243 | 19,595,674 | 2021-07-07 |
What was the dosage of drug 'ETOPOSIDE'? | BeEAM conditioning regimen is a safe, efficacious and economical alternative to BEAM chemotherapy.
In many stem cell transplant centres, BCNU, etoposide, cytarabine and melphalan (BEAM) high-dose chemotherapy (HDCT) has been replaced by the more economic and available bendamustine, etoposide, cytarabine, melphalan (BeE... | ON DAYS ?5 TO ?2, AS A 120 MIN INFUSION IN 1000 ML 0.9% NACL | DrugDosageText | CC BY | 34234243 | 19,595,674 | 2021-07-07 |
What was the dosage of drug 'MELPHALAN'? | BeEAM conditioning regimen is a safe, efficacious and economical alternative to BEAM chemotherapy.
In many stem cell transplant centres, BCNU, etoposide, cytarabine and melphalan (BEAM) high-dose chemotherapy (HDCT) has been replaced by the more economic and available bendamustine, etoposide, cytarabine, melphalan (BeE... | SINGLE 60 MIN INFUSION IN 1000?ML 0.9% NACL | DrugDosageText | CC BY | 34234243 | 19,595,674 | 2021-07-07 |
What was the dosage of drug 'SULFAMETHOXAZOLE\TRIMETHOPRIM'? | BeEAM conditioning regimen is a safe, efficacious and economical alternative to BEAM chemotherapy.
In many stem cell transplant centres, BCNU, etoposide, cytarabine and melphalan (BEAM) high-dose chemotherapy (HDCT) has been replaced by the more economic and available bendamustine, etoposide, cytarabine, melphalan (BeE... | 800/160 MG THREE TIMES PER WEEK | DrugDosageText | CC BY | 34234243 | 19,595,674 | 2021-07-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Remarkable Response to Olaparib in a Patient with Combined Hepatocellular-Cholangiocarcinoma Harboring a Biallelic BRCA2 Mutation.
Combined hepatocellular cholangiocarcinoma (cHCC-CC) is a rare subtype of primary liver malignancy characterized by aggressive behavior and poor prognosis. Radial surgical resection is the ... | CISPLATIN, GEMCITABINE HYDROCHLORIDE, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 34234458 | 19,656,271 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Remarkable Response to Olaparib in a Patient with Combined Hepatocellular-Cholangiocarcinoma Harboring a Biallelic BRCA2 Mutation.
Combined hepatocellular cholangiocarcinoma (cHCC-CC) is a rare subtype of primary liver malignancy characterized by aggressive behavior and poor prognosis. Radial surgical resection is the ... | CISPLATIN, GEMCITABINE, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 34234458 | 19,677,584 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Remarkable Response to Olaparib in a Patient with Combined Hepatocellular-Cholangiocarcinoma Harboring a Biallelic BRCA2 Mutation.
Combined hepatocellular cholangiocarcinoma (cHCC-CC) is a rare subtype of primary liver malignancy characterized by aggressive behavior and poor prognosis. Radial surgical resection is the ... | CISPLATIN, GEMCITABINE, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 34234458 | 19,645,817 | 2021 |
What was the administration route of drug 'PACLITAXEL'? | Remarkable Response to Olaparib in a Patient with Combined Hepatocellular-Cholangiocarcinoma Harboring a Biallelic BRCA2 Mutation.
Combined hepatocellular cholangiocarcinoma (cHCC-CC) is a rare subtype of primary liver malignancy characterized by aggressive behavior and poor prognosis. Radial surgical resection is the ... | Intravenous drip | DrugAdministrationRoute | CC BY-NC | 34234458 | 19,645,817 | 2021 |
What was the dosage of drug 'GEMCITABINE HYDROCHLORIDE'? | Remarkable Response to Olaparib in a Patient with Combined Hepatocellular-Cholangiocarcinoma Harboring a Biallelic BRCA2 Mutation.
Combined hepatocellular cholangiocarcinoma (cHCC-CC) is a rare subtype of primary liver malignancy characterized by aggressive behavior and poor prognosis. Radial surgical resection is the ... | UNK, CYCLIC (3 CYCLES) | DrugDosageText | CC BY-NC | 34234458 | 19,656,271 | 2021 |
What was the dosage of drug 'GEMCITABINE'? | Remarkable Response to Olaparib in a Patient with Combined Hepatocellular-Cholangiocarcinoma Harboring a Biallelic BRCA2 Mutation.
Combined hepatocellular cholangiocarcinoma (cHCC-CC) is a rare subtype of primary liver malignancy characterized by aggressive behavior and poor prognosis. Radial surgical resection is the ... | UNK, 3 CYCLES | DrugDosageText | CC BY-NC | 34234458 | 19,677,584 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Differentiation syndrome'. | Differentiation Syndrome with Severe Abdominal Pain During Induction Treatment of Acute Promyelocytic Leukemia: A Case Report.
Acute promyelocytic leukemia differentiation syndrome (APL DS) is a common and severe complication seen in patients with APL treated with all-trans retinoic acid (ATRA) and/or arsenic trioxide ... | ARSENIC TRIOXIDE, IDARUBICIN, TRETINOIN | DrugsGivenReaction | CC BY-NC | 34234544 | 19,663,144 | 2021 |
What was the outcome of reaction 'Differentiation syndrome'? | Differentiation Syndrome with Severe Abdominal Pain During Induction Treatment of Acute Promyelocytic Leukemia: A Case Report.
Acute promyelocytic leukemia differentiation syndrome (APL DS) is a common and severe complication seen in patients with APL treated with all-trans retinoic acid (ATRA) and/or arsenic trioxide ... | Recovered | ReactionOutcome | CC BY-NC | 34234544 | 19,663,144 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bradycardia'. | Cardiotoxicity and Cardiac Monitoring Among Anthracycline-Treated Cancer Patients: A Retrospective Cohort Study.
Cardiotoxicity is a common complication associated with anthracyclines. Little is known regarding the rate of anthracyclines-related acute and chronic cardiotoxicity and adherence to cardiac monitoring recom... | DOXORUBICIN, FILGRASTIM | DrugsGivenReaction | CC BY-NC | 34234558 | 19,589,914 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bundle branch block'. | Cardiotoxicity and Cardiac Monitoring Among Anthracycline-Treated Cancer Patients: A Retrospective Cohort Study.
Cardiotoxicity is a common complication associated with anthracyclines. Little is known regarding the rate of anthracyclines-related acute and chronic cardiotoxicity and adherence to cardiac monitoring recom... | DOXORUBICIN, FILGRASTIM | DrugsGivenReaction | CC BY-NC | 34234558 | 19,589,914 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | Cardiotoxicity and Cardiac Monitoring Among Anthracycline-Treated Cancer Patients: A Retrospective Cohort Study.
Cardiotoxicity is a common complication associated with anthracyclines. Little is known regarding the rate of anthracyclines-related acute and chronic cardiotoxicity and adherence to cardiac monitoring recom... | DOXORUBICIN, FILGRASTIM | DrugsGivenReaction | CC BY-NC | 34234558 | 19,589,914 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiotoxicity'. | Cardiotoxicity and Cardiac Monitoring Among Anthracycline-Treated Cancer Patients: A Retrospective Cohort Study.
Cardiotoxicity is a common complication associated with anthracyclines. Little is known regarding the rate of anthracyclines-related acute and chronic cardiotoxicity and adherence to cardiac monitoring recom... | DOXORUBICIN, FILGRASTIM | DrugsGivenReaction | CC BY-NC | 34234558 | 19,589,914 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ejection fraction decreased'. | Cardiotoxicity and Cardiac Monitoring Among Anthracycline-Treated Cancer Patients: A Retrospective Cohort Study.
Cardiotoxicity is a common complication associated with anthracyclines. Little is known regarding the rate of anthracyclines-related acute and chronic cardiotoxicity and adherence to cardiac monitoring recom... | DOXORUBICIN, FILGRASTIM | DrugsGivenReaction | CC BY-NC | 34234558 | 19,589,914 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sinus tachycardia'. | Cardiotoxicity and Cardiac Monitoring Among Anthracycline-Treated Cancer Patients: A Retrospective Cohort Study.
Cardiotoxicity is a common complication associated with anthracyclines. Little is known regarding the rate of anthracyclines-related acute and chronic cardiotoxicity and adherence to cardiac monitoring recom... | DOXORUBICIN, FILGRASTIM | DrugsGivenReaction | CC BY-NC | 34234558 | 19,589,914 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tachyarrhythmia'. | Cardiotoxicity and Cardiac Monitoring Among Anthracycline-Treated Cancer Patients: A Retrospective Cohort Study.
Cardiotoxicity is a common complication associated with anthracyclines. Little is known regarding the rate of anthracyclines-related acute and chronic cardiotoxicity and adherence to cardiac monitoring recom... | DOXORUBICIN, FILGRASTIM | DrugsGivenReaction | CC BY-NC | 34234558 | 19,589,914 | 2021 |
What was the administration route of drug 'ACETAMINOPHEN'? | Lamotrigine Reduces Stress Symptoms of Chronic Anxiety in the Times of the Covid-19 Natural Catastrophe-A Case Report.
The SARS-CoV-2 pandemic has been a worldwide chronic, stress-inducing natural catastrophe associated with increased emotional challenging. Patients with Post-traumatic stress disorder (PTSD), self-inju... | Oral | DrugAdministrationRoute | CC BY | 34234698 | 20,707,558 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Interest of Fluvoxamine as an Add-On to Clozapine in Children With Severe Psychiatric Disorder According to CYP Polymorphisms: Experience From a Case Series.
Despite its drastic efficacy in resistant psychiatric disorders, clozapine remains rarely used in youth due to its side effects. Clozapine plasma level is determi... | CLOZAPINE, FLUVOXAMINE, LEVOMEPROMAZINE | DrugsGivenReaction | CC BY | 34234701 | 19,603,641 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Interest of Fluvoxamine as an Add-On to Clozapine in Children With Severe Psychiatric Disorder According to CYP Polymorphisms: Experience From a Case Series.
Despite its drastic efficacy in resistant psychiatric disorders, clozapine remains rarely used in youth due to its side effects. Clozapine plasma level is determi... | CLOZAPINE, FLUVOXAMINE, LEVOMEPROMAZINE | DrugsGivenReaction | CC BY | 34234701 | 19,603,641 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QT prolonged'. | Interest of Fluvoxamine as an Add-On to Clozapine in Children With Severe Psychiatric Disorder According to CYP Polymorphisms: Experience From a Case Series.
Despite its drastic efficacy in resistant psychiatric disorders, clozapine remains rarely used in youth due to its side effects. Clozapine plasma level is determi... | CLOZAPINE, FLUVOXAMINE, LEVOMEPROMAZINE | DrugsGivenReaction | CC BY | 34234701 | 19,603,641 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Overdose'. | Interest of Fluvoxamine as an Add-On to Clozapine in Children With Severe Psychiatric Disorder According to CYP Polymorphisms: Experience From a Case Series.
Despite its drastic efficacy in resistant psychiatric disorders, clozapine remains rarely used in youth due to its side effects. Clozapine plasma level is determi... | CLOZAPINE, FLUVOXAMINE, LEVOMEPROMAZINE | DrugsGivenReaction | CC BY | 34234701 | 19,603,641 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Interest of Fluvoxamine as an Add-On to Clozapine in Children With Severe Psychiatric Disorder According to CYP Polymorphisms: Experience From a Case Series.
Despite its drastic efficacy in resistant psychiatric disorders, clozapine remains rarely used in youth due to its side effects. Clozapine plasma level is determi... | CLOZAPINE, FLUVOXAMINE, LEVOMEPROMAZINE | DrugsGivenReaction | CC BY | 34234701 | 19,603,641 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sedation'. | Interest of Fluvoxamine as an Add-On to Clozapine in Children With Severe Psychiatric Disorder According to CYP Polymorphisms: Experience From a Case Series.
Despite its drastic efficacy in resistant psychiatric disorders, clozapine remains rarely used in youth due to its side effects. Clozapine plasma level is determi... | CLOZAPINE, FLUVOXAMINE, LEVOMEPROMAZINE | DrugsGivenReaction | CC BY | 34234701 | 19,603,641 | 2021 |
What was the dosage of drug 'CLOZAPINE'? | Interest of Fluvoxamine as an Add-On to Clozapine in Children With Severe Psychiatric Disorder According to CYP Polymorphisms: Experience From a Case Series.
Despite its drastic efficacy in resistant psychiatric disorders, clozapine remains rarely used in youth due to its side effects. Clozapine plasma level is determi... | 300 mg (milligrams). | DrugDosage | CC BY | 34234701 | 19,603,641 | 2021 |
What was the dosage of drug 'FLUVOXAMINE'? | Interest of Fluvoxamine as an Add-On to Clozapine in Children With Severe Psychiatric Disorder According to CYP Polymorphisms: Experience From a Case Series.
Despite its drastic efficacy in resistant psychiatric disorders, clozapine remains rarely used in youth due to its side effects. Clozapine plasma level is determi... | 50 mg (milligrams). | DrugDosage | CC BY | 34234701 | 19,603,641 | 2021 |
What was the dosage of drug 'LEVOMEPROMAZINE'? | Interest of Fluvoxamine as an Add-On to Clozapine in Children With Severe Psychiatric Disorder According to CYP Polymorphisms: Experience From a Case Series.
Despite its drastic efficacy in resistant psychiatric disorders, clozapine remains rarely used in youth due to its side effects. Clozapine plasma level is determi... | 15 mg (milligrams). | DrugDosage | CC BY | 34234701 | 19,603,641 | 2021 |
What was the outcome of reaction 'Overdose'? | Interest of Fluvoxamine as an Add-On to Clozapine in Children With Severe Psychiatric Disorder According to CYP Polymorphisms: Experience From a Case Series.
Despite its drastic efficacy in resistant psychiatric disorders, clozapine remains rarely used in youth due to its side effects. Clozapine plasma level is determi... | Not recovered | ReactionOutcome | CC BY | 34234701 | 19,603,641 | 2021 |
What was the outcome of reaction 'Product use in unapproved indication'? | Interest of Fluvoxamine as an Add-On to Clozapine in Children With Severe Psychiatric Disorder According to CYP Polymorphisms: Experience From a Case Series.
Despite its drastic efficacy in resistant psychiatric disorders, clozapine remains rarely used in youth due to its side effects. Clozapine plasma level is determi... | Not recovered | ReactionOutcome | CC BY | 34234701 | 19,603,641 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arthritis gonococcal'. | Diffuse Gonococcal Infection (DGI) in a Patient with Treatment-Refractory Acetylcholine Receptor Antibody-Positive (AChR+) Generalized Myasthenia Gravis (gMG) Treated with Eculizumab.
Patients receiving complement inhibitor, eculizumab, are at high risk for infections with encapsulated organisms such as Neisseria due t... | ECULIZUMAB, PYRIDOSTIGMINE | DrugsGivenReaction | CC BY | 34234969 | 19,581,291 | 2021 |
What was the outcome of reaction 'Arthritis gonococcal'? | Diffuse Gonococcal Infection (DGI) in a Patient with Treatment-Refractory Acetylcholine Receptor Antibody-Positive (AChR+) Generalized Myasthenia Gravis (gMG) Treated with Eculizumab.
Patients receiving complement inhibitor, eculizumab, are at high risk for infections with encapsulated organisms such as Neisseria due t... | Recovered | ReactionOutcome | CC BY | 34234969 | 19,581,291 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Presence of a Septal Occluder Is No Longer an Obstacle for Pulmonary Vein Isolation by Cryoablation.
Cryoablation for pulmonary vein isolation in atrial fibrillation has been considered a relative contraindication in the presence of a septal occluder device. We describe the successful conduct of this technique with a m... | METOPROLOL, PROPAFENONE | DrugsGivenReaction | CC BY | 34234987 | 19,835,867 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal disorder'. | Presence of a Septal Occluder Is No Longer an Obstacle for Pulmonary Vein Isolation by Cryoablation.
Cryoablation for pulmonary vein isolation in atrial fibrillation has been considered a relative contraindication in the presence of a septal occluder device. We describe the successful conduct of this technique with a m... | METOPROLOL, PROPAFENONE | DrugsGivenReaction | CC BY | 34234987 | 19,835,867 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Idiopathic intracranial hypertension'. | Isolated Sixth Nerve Palsy: A Case of Pseudotumor Cerebri and an Overview of the Evolutionary Dynamic Geometry of Dorello's Canal.
The dynamics of increased intracranial pressure (ICP) and sixth cranial nerve palsy has undergone a paradigm shift, with emphasis shifting from a length hypothesis to a theory based on nove... | MINOCYCLINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34235019 | 19,613,895 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'VIth nerve paralysis'. | Isolated Sixth Nerve Palsy: A Case of Pseudotumor Cerebri and an Overview of the Evolutionary Dynamic Geometry of Dorello's Canal.
The dynamics of increased intracranial pressure (ICP) and sixth cranial nerve palsy has undergone a paradigm shift, with emphasis shifting from a length hypothesis to a theory based on nove... | MINOCYCLINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34235019 | 19,613,895 | 2021-05 |
What is the weight of the patient? | Isolated Sixth Nerve Palsy: A Case of Pseudotumor Cerebri and an Overview of the Evolutionary Dynamic Geometry of Dorello's Canal.
The dynamics of increased intracranial pressure (ICP) and sixth cranial nerve palsy has undergone a paradigm shift, with emphasis shifting from a length hypothesis to a theory based on nove... | 109.32 kg. | Weight | CC BY | 34235019 | 19,613,895 | 2021-05 |
What was the outcome of reaction 'Idiopathic intracranial hypertension'? | Isolated Sixth Nerve Palsy: A Case of Pseudotumor Cerebri and an Overview of the Evolutionary Dynamic Geometry of Dorello's Canal.
The dynamics of increased intracranial pressure (ICP) and sixth cranial nerve palsy has undergone a paradigm shift, with emphasis shifting from a length hypothesis to a theory based on nove... | Recovered | ReactionOutcome | CC BY | 34235019 | 19,613,895 | 2021-05 |
What was the outcome of reaction 'VIth nerve paralysis'? | Isolated Sixth Nerve Palsy: A Case of Pseudotumor Cerebri and an Overview of the Evolutionary Dynamic Geometry of Dorello's Canal.
The dynamics of increased intracranial pressure (ICP) and sixth cranial nerve palsy has undergone a paradigm shift, with emphasis shifting from a length hypothesis to a theory based on nove... | Recovered | ReactionOutcome | CC BY | 34235019 | 19,613,895 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Pericardial Angiosarcoma: A Diagnostic Challenge.
Cardiac angiosarcomas are the most common malignant primary cardiac tumors accounting for 31% of all primary cardiac tumors. However, primary pericardial angiosarcomas are extremely rare and are associated with high mortality. A 41-year-old male with a past medical hist... | PACLITAXEL | DrugsGivenReaction | CC BY | 34235027 | 19,595,696 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancytopenia'. | Pericardial Angiosarcoma: A Diagnostic Challenge.
Cardiac angiosarcomas are the most common malignant primary cardiac tumors accounting for 31% of all primary cardiac tumors. However, primary pericardial angiosarcomas are extremely rare and are associated with high mortality. A 41-year-old male with a past medical hist... | PACLITAXEL | DrugsGivenReaction | CC BY | 34235027 | 19,595,696 | 2021-05 |
What was the dosage of drug 'PACLITAXEL'? | Pericardial Angiosarcoma: A Diagnostic Challenge.
Cardiac angiosarcomas are the most common malignant primary cardiac tumors accounting for 31% of all primary cardiac tumors. However, primary pericardial angiosarcomas are extremely rare and are associated with high mortality. A 41-year-old male with a past medical hist... | SINGLE CYCLE | DrugDosageText | CC BY | 34235027 | 19,595,696 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal discomfort'. | Acute glomerulonephritis in a hematopoietic blood stem cell donor.
Use of granulocyte colony-stimulating factor (G-CSF) has been associated with side effects including reports of acute glomerulonephritis (GN), almost all of which have been immune complex associated. There is one prior report of pauci-immune GN in a chi... | FILGRASTIM | DrugsGivenReaction | CC BY | 34235045 | 20,045,361 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bone pain'. | Acute glomerulonephritis in a hematopoietic blood stem cell donor.
Use of granulocyte colony-stimulating factor (G-CSF) has been associated with side effects including reports of acute glomerulonephritis (GN), almost all of which have been immune complex associated. There is one prior report of pauci-immune GN in a chi... | FILGRASTIM | DrugsGivenReaction | CC BY | 34235045 | 20,045,361 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Glomerulonephritis'. | Acute glomerulonephritis in a hematopoietic blood stem cell donor.
Use of granulocyte colony-stimulating factor (G-CSF) has been associated with side effects including reports of acute glomerulonephritis (GN), almost all of which have been immune complex associated. There is one prior report of pauci-immune GN in a chi... | FILGRASTIM | DrugsGivenReaction | CC BY | 34235045 | 20,045,361 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oropharyngeal pain'. | Acute glomerulonephritis in a hematopoietic blood stem cell donor.
Use of granulocyte colony-stimulating factor (G-CSF) has been associated with side effects including reports of acute glomerulonephritis (GN), almost all of which have been immune complex associated. There is one prior report of pauci-immune GN in a chi... | FILGRASTIM | DrugsGivenReaction | CC BY | 34235045 | 20,045,361 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Acute glomerulonephritis in a hematopoietic blood stem cell donor.
Use of granulocyte colony-stimulating factor (G-CSF) has been associated with side effects including reports of acute glomerulonephritis (GN), almost all of which have been immune complex associated. There is one prior report of pauci-immune GN in a chi... | FILGRASTIM | DrugsGivenReaction | CC BY | 34235045 | 20,045,361 | 2021 |
What was the dosage of drug 'FILGRASTIM'? | Acute glomerulonephritis in a hematopoietic blood stem cell donor.
Use of granulocyte colony-stimulating factor (G-CSF) has been associated with side effects including reports of acute glomerulonephritis (GN), almost all of which have been immune complex associated. There is one prior report of pauci-immune GN in a chi... | 10 UG/KG DAILY; 3 DOSES OF FILGRASTIM | DrugDosageText | CC BY | 34235045 | 20,045,361 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fanconi syndrome acquired'. | Ifosfamide-induced nephrogenic diabetes insipidus responsive to supraphysiologic doses of intravenous desmopressin.
Nephrogenic diabetes insipidus (DI) refers to the reduction in the ability of the kidney to concentrate urine, which can be caused by partial or complete resistance at the site of action of anti-diuretic ... | DOXORUBICIN, IFOSFAMIDE, METAXALONE, MORPHINE, OMEPRAZOLE, ONDANSETRON, SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B | DrugsGivenReaction | CC BY | 34235046 | 20,008,568 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephropathy toxic'. | Ifosfamide-induced nephrogenic diabetes insipidus responsive to supraphysiologic doses of intravenous desmopressin.
Nephrogenic diabetes insipidus (DI) refers to the reduction in the ability of the kidney to concentrate urine, which can be caused by partial or complete resistance at the site of action of anti-diuretic ... | DOXORUBICIN, IFOSFAMIDE | DrugsGivenReaction | CC BY | 34235046 | 19,748,757 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.